Shares of Health Care sector company Catalent moved 1.6% today, and are now trading at a price of $46.24. The large-cap stock's daily volume was 132,426 compared to its average volume of 3,864,930. The S&P 500 index returned a 1.0% performance.
Catalent, Inc., together with its subsidiaries, develops and manufactures solutions for drugs, protein-based biologics, cell and gene therapies, and consumer health products worldwide. The company is based in Somerset and has 19,000 full time employees. Its market capitalization is $8,335,777,792.
13 analysts are following Catalent and have set target prices ranging from $37.0 to $86.0 per share. On average, they have given the company a rating of hold. At today's prices, CTLT is trading -7.8% away from its average analyst target price of $50.15 per share.
Over the last year, CTLT shares have gone down by -58.0%, which represents a difference of -67.0% when compared to the S&P 500. The stock's 52 week high is $115.08 per share and its 52 week low is $31.45. With average free cash flows of $897.25 Million that have been growing at an average rate of 24.0% over the last 4 years, Catalent declining stock performance may not be reflective of the quality of its underlying business.
| Date Reported | Cash Flow from Operations ($ k) | Capital expenditures ($ k) | Free Cashflow ($ k) | YoY Growth (%) |
|---|---|---|---|---|
| 2022-08-29 | 439,000 | -660,000 | 1,099,000 | -1.79 |
| 2021-08-30 | 433,000 | -686,000 | 1,119,000 | 23.51 |
| 2020-08-31 | 440,000 | -466,000 | 906,000 | 94.84 |
| 2019-08-27 | 248,000 | -217,000 | 465,000 | n/a |
